E
Xenon Pharmaceuticals Inc. XENE
$37.51 -$0.68-1.78% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue 42.00% 31.99% 25.60% 19.06% 20.36%
Gross Profit -37.78% -27.63% -25.60% -19.06% -20.46%
SG&A Expenses 22.44% 41.22% 48.05% 49.72% 55.05%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 37.09% 34.12% 30.48% 25.44% 27.52%
Operating Income -33.93% -30.78% -30.48% -25.44% -27.61%
Income Before Tax -41.76% -35.36% -30.51% -22.90% -22.21%
Income Tax Expenses -1,443.11% -2,296.47% -1,300.34% -142.40% -145.50%
Earnings from Continuing Operations -39.77% -33.32% -28.48% -21.90% -21.58%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -39.77% -33.32% -28.48% -21.90% -21.58%
EBIT -33.93% -30.78% -30.48% -25.44% -27.61%
EBITDA -35.01% -31.83% -31.47% -26.08% -26.81%
EPS Basic -29.45% -18.59% -10.19% -5.63% -9.83%
Normalized Basic EPS -30.82% -19.25% -9.77% -3.35% -7.73%
EPS Diluted -29.45% -18.59% -10.19% -5.63% -9.83%
Normalized Diluted EPS -30.82% -19.25% -9.77% -3.35% -7.73%
Average Basic Shares Outstanding 7.80% 11.90% 16.45% 15.16% 10.86%
Average Diluted Shares Outstanding 7.80% 11.90% 16.45% 15.16% 10.86%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --